IMPROVING THE PREDICTION OF PHARMACOGENES USING TEXT-DERIVED DRUG-GENE RELATIONSHIPS
Open Access
- 1 October 2009
- book chapter
- research article
- Published by World Scientific Pub Co Pte Ltd
Abstract
A critical goal of pharmacogenomics research is to identify genes that can explain variation in drug response. We have previously reported a method that creates a genome-scale ranking of genes likely to interact with a drug. The algorithm uses information about drug structure and indications of use to rank the genes. Although the algorithm has good performance, its performance depends on a curated set of drug-gene relationships that is expensive to create and difficult to maintain. In this work, we assess the utility of text mining in extracting a network of drug-gene relationships automatically. This provides a valuable aggregate source of knowledge, subsequently used as input into the algorithm that ranks potential pharmacogenes. Using a drug-gene network created from sentence-level co-occurrence in the full text of scientific articles, we compared the performance to that of a network created by manual curation of those articles. Under a wide range of conditions, we show that a knowledge base derived from text-mining the literature performs as well as, and sometimes better than, a high-quality, manually curated knowledge base. We conclude that we can use relationships mined automatically from the literature as a knowledgebase for pharmacogenomics relationships. Additionally, when relationships are missed by text mining, our system can accurately extrapolate new relationships with 77.4% precision.Keywords
This publication has 27 references indexed in Scilit:
- Antidepressant Switching Among Adherent Patients Treated for DepressionPsychiatric Services, 2009
- Generating Genome-Scale Candidate Gene Lists for PharmacogenomicsClinical Pharmacology & Therapeutics, 2009
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin DosePLoS Genetics, 2009
- The microeconomics of personalized medicine: today's challenge and tomorrow's promiseNature Reviews Drug Discovery, 2009
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Journal of Clinical Oncology, 2009
- Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full textBMC Bioinformatics, 2009
- CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporineThe Pharmacogenomics Journal, 2008
- The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patientsPharmacogenetics, 2004
- Pharmacogenetics goes genomicNature Reviews Genetics, 2003
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsThe New England Journal of Medicine, 2003